JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states

References

• Verdin E, Ott M. 50 Years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol. 2014;16:258–264.
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhou MM. Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 2002;513:124–128.
   PubMed Web of Science ®Google Scholar
• Pérez-Salvia M, Esteller M. Bromodomain inhibitors and cancer therapy: from structures to applications. Epigenetics. 2017;12:323–339.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Qi J, Picaud S, et al. Selective inhibition of BET bromodomains. Nature. 2010;468:1067–1073.
   PubMed Web of Science ®Google Scholar
• Zuber J, Shi J, Wang E, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478:524–528.
   PubMed Web of Science ®Google Scholar
• Chapuy B, McKeown MR, Lin CY, et al. Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma. Cancer Cell. 2013;24:777–790.
   PubMed Web of Science ®Google Scholar
• Baker EK, Taylor S, Gupte A, et al. BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. Sci Rep. 2015;5:10120.
   Web of Science ®Google Scholar
• Asangani IA, Dommeti VL, Wang X, et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature. 2014;510:278–282.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Knapp S. Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Discov. 2014;13:337–356.
   PubMed Web of Science ®Google Scholar
• Zaware N, Zhou -M-M. Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation. Curr Opin Chem Biol. 2017;39:116–125.
   PubMed Web of Science ®Google Scholar
• Lockwood WW, Zejnullahu K, Bradner JE, et al. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proc Natl Acad Sci. 2012;109:19408–19413.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Picaud S, Mangos M, et al. Histone recognition and large-scale structural analysis of the human bromodomain family. Cell. 2012;149:214–231.
   PubMed Web of Science ®Google Scholar
• Baud MGJ, Lin-Shiao E, Cardote T, et al. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes. Science. 2014;346:638–641.
   PubMed Web of Science ®Google Scholar
• Zhang K, Williams KE, Huang L, et al. Histone acetylation and deacetylation: identification of acetylation and methylation sites of HeLa histone H4 by mass spectrometry. Mol Cell Proteomics. 2002;1:500–508.
   PubMed Web of Science ®Google Scholar
• Gilan O, Lam EYN, Becher I, et al. Functional interdependence of BRD4 and DOT1L in MLL leukemia. Nat Struct Mol Biol. 2016;23:673–681.
   PubMed Web of Science ®Google Scholar
• Lovén J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320–334.
   PubMed Web of Science ®Google Scholar
• Anders L, Guenther MG, Qi J, et al. Genome-wide localization of small molecules. Nat Biotechnol. 2014;32:92–96.
   PubMed Web of Science ®Google Scholar
• Donato E, Croci O, Sabò A, et al. Compensatory RNA polymerase 2 loading determines the efficacy and transcriptional selectivity of JQ1 in Myc-driven tumors. Leukemia. 2017;31:479–490.
   PubMed Web of Science ®Google Scholar
• Klingbeil O, Lesche R, Gelato KA, et al. Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents. Cell Death Dis. 2016;7:e2365.
   PubMed Web of Science ®Google Scholar
• Shimamura T, Chen Z, Soucheray M, et al. Efficacy of BET bromodomain inhibition in KRAS-mutant non-small cell lung cancer. Clin Cancer Res. 2013;19:6183–6192.
   PubMed Web of Science ®Google Scholar
• Forrest AR, Kawaji H, Rehli M, et al. A promoter-level mammalian expression atlas. Nature. 2014;507:462–470.
   PubMed Web of Science ®Google Scholar
• Wakamori M, Fujii Y, Suka N, et al. Intra- and inter-nucleosomal interactions of the histone H4 tail revealed with a human nucleosome core particle with genetically-incorporated H4 tetra-acetylation. Sci Rep. 2015;5:17204.
   PubMed Web of Science ®Google Scholar
• Moriniere J, Rousseaux S, Steuerwald U, et al. Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature. 2009;461:664–668.
   PubMed Web of Science ®Google Scholar
• Hayashi-Takanaka Y, Maehara K, Harada A, et al. Distribution of histone H4 modifications as revealed by a panel of specific monoclonal antibodies. Chromosom Res. 2015;23:753–766.
   PubMed Web of Science ®Google Scholar
• Bernstein BE, Birney E, Dunham I, et al. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57–74.
   PubMed Web of Science ®Google Scholar
• Ernst J, Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat Methods. 2012;9:215–216.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Liu P, Young AN, et al. Loss of HOXC6 expression induces apoptosis in prostate cancer cells. Oncogene. 2005;24:188–198.
   PubMed Web of Science ®Google Scholar
• Moon S-M, Kim S-A, Yoon J-H, et al. HOXC6 is deregulated in human head and neck squamous cell carcinoma and modulates Bcl-2 expression. J Biol Chem. 2012;287:35678–35688.
   PubMed Web of Science ®Google Scholar
• Rathert P, Roth M, Neumann T, et al. Transcriptional plasticity promotes primary and acquired resistance to BET inhibition. Nature. 2015;525:543–547.
   PubMed Web of Science ®Google Scholar
• Fong CY, Gilan O, Lam EYN, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538–542.
   PubMed Web of Science ®Google Scholar
• Shu S, Lin CY, He HH, et al. Response and resistance to BET bromodomain inhibitors in triple negative breast cancer. Nature. 2016;67:413–417.
   Google Scholar
• Balwierz PJ, Pachkov M, Arnold P, et al. ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs. Genome Res. 2014;24:869–884.
   PubMed Web of Science ®Google Scholar
• Heinz S, Benner C, Spann N, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576–589.
   PubMed Web of Science ®Google Scholar
• Cheung KL, Zhang F, Jaganathan A, et al. Distinct roles of Brd2 and Brd4 in potentiating the transcriptional program for Th17 cell differentiation. Mol Cell. 2017;65:1068–1080.
   Web of Science ®Google Scholar
• Hsu SC, Gilgenast TG, Bartman CR, et al. The BET protein BRD2 cooperates with CTCF to enforce transcriptional and architectural boundaries. Mol Cell. 2017;66:102–116.
   PubMed Web of Science ®Google Scholar
• Bradbury A, Plückthun A. Reproducibility: standardize antibodies used in research. Nature. 2015;518:27–29.
   PubMed Web of Science ®Google Scholar
• Baker M. Reproducibility crisis: blame it on the antibodies. Nature. 2015;521:274–276.
   PubMed Web of Science ®Google Scholar
• Nicodeme E, Jeffrey KL, Schaefer U, et al. Suppression of inflammation by a synthetic histone mimic. Nature. 2010;468:1119–1123.
   PubMed Web of Science ®Google Scholar
• Sinha A, Faller DV, Denis GV. Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem J. 2005;387:257–269.
   PubMed Web of Science ®Google Scholar
• Mazur PK, Herner A, Mello SS, et al. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma. Nat Med. 2015;21:1163–1171.
   PubMed Web of Science ®Google Scholar
• Meng S, Zhang L, Tang Y, et al. BET inhibitor JQ1 blocks inflammation and bone destruction. J Dent Res. 2014;93:657–662.
   PubMed Web of Science ®Google Scholar
• Delmore JE, Issa GC, Lemieux ME, et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011;146:904–917.
   PubMed Web of Science ®Google Scholar
• Mertz JA, Conery AR, Bryant BM, et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci. 2011;108:16669–16674.
   PubMed Web of Science ®Google Scholar
• Pérez-Salvia M, Simó-Riudalbas L, Llinàs-Arias P, et al. Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer. Oncotarget. 2017;8:51621–51629.
   PubMedGoogle Scholar
• Li J, Sutter C, Parker DS, et al. CBP/p300 are bimodal regulators of Wnt signaling. EMBO J. 2007;26:2284–2294.
   PubMed Web of Science ®Google Scholar
• Nguyen DX, Chiang AC, Zhang XHF, et al. WNT/TCF Signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell. 2009;138:51–62.
   PubMed Web of Science ®Google Scholar
• Desmet CJ, Gallenne T, Prieur A, et al. Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis. Proc Natl Acad Sci U S A. 2013;110:5139–5144.
   PubMed Web of Science ®Google Scholar
• Xu X, Bieda M, Jin VX, et al. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. Genome Res. 2007;17:1550–1561.
   PubMed Web of Science ®Google Scholar
• Lee EY, Cam H, Ziebold U, et al. E2F4 loss suppresses tumorigenesis in Rb mutant mice. Cancer Cell. 2002;2:463–472.
   PubMed Web of Science ®Google Scholar
• Gordon S, Akopyan G, Garban H, et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 2006;25:1125–1142.
   PubMed Web of Science ®Google Scholar
• Lee BK, Bhinge AA, Iyer VR. Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis. Nucleic Acids Res. 2011;39:3558–3573.
   PubMed Web of Science ®Google Scholar
• Larsen JE, Nathan V, Osborne JK, et al. ZEB1 drives epithelial-to-mesenchymal transition in lung cancer. J Clin Invest. 2016;126:3219–3235.
   PubMed Web of Science ®Google Scholar
• Andrieu GP, Denis GV. BET proteins exhibit transcriptional and functional opposition in the epithelial-to-mesenchymal transition. Mol Cancer Res. 2018;16:580–586.
   PubMed Web of Science ®Google Scholar
• Fernandez-Alonso R, Davidson L, Hukelmann J, et al. Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification. EMBO Rep. 2017;18:1108–1122.
   PubMed Web of Science ®Google Scholar
• Hsu SC, Blobel GA. The role of bromodomain and extraterminal motif (BET) proteins in chromatin structure. Cold Spring Harb Symp Quant Biol. 2017;82:37–43.
   PubMedGoogle Scholar
• Mukai T, Yanagisawa T, Ohtake K, et al. Genetic-code evolution for protein synthesis with non-natural amino acids. Biochem Biophys Res Commun. 2011;411:757–761.
   PubMed Web of Science ®Google Scholar
• Zhu YY, Machleder EM, Chenchik A, et al. Reverse transcriptase template switching: A SMARTtm approach for full-length cDNA library construction. Biotechniques. 2001;30:892–897.
   PubMed Web of Science ®Google Scholar
• Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326.
   PubMed Web of Science ®Google Scholar
• McCoy AJ, Grosse-Kunstleve RW, Adams PD, et al. Phaser crystallographic software. J Appl Crystallogr. 2007;40:658–674.
   PubMed Web of Science ®Google Scholar
• Emsley P, Lohkamp B, Scott WG, et al. Features and development of coot. Acta Crystallogr Sect D Biol Crystallogr. 2010;66:486–501.
   PubMed Web of Science ®Google Scholar
• Adams PD, Afonine PV, Bunkóczi G, et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr Sect D Biol Crystallogr. 2010;66:213–221.
   PubMed Web of Science ®Google Scholar
• Sato Y, Kujirai T, Arai R, et al. A genetically encoded probe for live-cell imaging of H4K20 monomethylation. J Mol Biol. 2016;428:3885–3902.
   PubMed Web of Science ®Google Scholar
• Kimura H, Hayashi-Takanaka Y, Goto Y, et al. The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct Funct. 2008;33:61–73.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139–140.
   PubMed Web of Science ®Google Scholar
• Kodzius R, Kojima M, Nishiyori H, et al. CAGE: cap analysis of gene expression. Nat Methods. 2006;3:211–222.
   PubMed Web of Science ®Google Scholar
• Hon -C-C, Ramilowski JA, Harshbarger J, et al. An atlas of human long non-coding RNAs with accurate 5’ ends. Nature. 2017;543:199–204.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci. 2005;102:15545–15550.
   PubMed Web of Science ®Google Scholar
• Feng J, Liu T, Qin B, et al. Identifying ChIP-seq enrichment using MACS. Nat Protoc. 2012;7:1728–1740.
   PubMed Web of Science ®Google Scholar
• Akalin A, Franke V, Vlahoviček K, et al. Genomation: A toolkit to summarize, annotate and visualize genomic intervals. Bioinformatics. 2015;31:1127–1129.
   PubMed Web of Science ®Google Scholar
• Whyte WA, Orlando DA, Hnisz D, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153:307–319.
   PubMed Web of Science ®Google Scholar
• Arner E, Daub CO, Vitting-Seerup K, et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015;347:1010–1014.
   PubMed Web of Science ®Google Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455–461.
   PubMed Web of Science ®Google Scholar
• Shen L, Shao N, Liu X, et al. ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics. 2014;15:284.
   PubMed Web of Science ®Google Scholar